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Summary The micronucleus (MN) test has been carefully characterised in four human tumour cell lines of
widely differing radiosensitivity. Two radioresistant bladder carcinoma cell lines (MGH-U1 and RT112), one
sensitive medulloblastoma cell line (D283MED) and a sensitive neuroblasoma cell line (HX142) were used.
The number of MN per Gy of ionising radiation was 0.13 for HX142, 0.17 for D283MED, 0.21 for RT112
and 0.26 for MGH-U1. This does not rank the cell lines in the same order of radiosensitivity as clonogenic cell
survival where the surviving fraction at 2 Gy (SF2) was 0.11 for HX142, 0.2 for D283MED, 0.62 for RTI 12
and 0.53 for MGH-U1. This discrepancy between MN formation and cell death leaves doubt as to the
potential usefulness of the MN test as a rapid assay of radiosensitivity but it has potential implications for the
mechanistic basis of radiosensitivity in these cells.
Micronuclei (MN) are formed when chromosomal fragments
behave independently of the remaining chromosomes during
the division of damaged cells. The presence of MN is thus
considered to reflect genotoxic damage. The MN test has
been applied to studies of environmental and industrial
hazards (Heddle et al., 1983; Heddle et al., 1990; Meng &
Zhang, 1990). The relationship between genotoxicity, as
measured by the MN test and cytotoxic damage following
ionising radiation treatment has been investigated by a
number of authors and a general correlation has usually been
found between MN formation and slow growth or the
absence ofcolony formation (Joshi et al., 1982; Stap & Aten,
1990). Also MN frequency changes in proportion to cell kill
when a given cell type is irradiated under various conditions
(Midander & Revesz, 1980).
Due to its simplicity there has been much interest in
exploiting this relationship between MN frequency and
cytotoxicity to provide a rapid test of radiosensitivity in
human cells. In particular the use of the MN test as a
predictive test of human tumour cell radiosensitivity is being
explored (Peters et al., 1986; Streffer et al., 1986). Fenech and
Morley (1985, 1986) established the cytokinesis-block method
as the simplest and most precise application of the MN test.
The blocking of cytokinesis by the use of Cytochalasin-B
enables identification of cells in their first post-treatment
mitotic division by the production of binucleate cells (BNC).
This overcomes one of the major cell kinetic problems which
plague the micronucleus test.
A complication of the MN test in non-diploid cells was
identified by Revell and his colleagues (Revell, 1983). Frag-
ment loss in a pure diploid Syrian hamster cell line, as
detected by MN formation, correlated on a 1:1 basis with
inhibited growth. However, a spontaneous tetraploid variant
required on average 2 MN per lethal event while a hypotet-
raploid variant required >2 MN per lethal event. Thus in
non-diploid cell lines the direct correlation between MN
formation and cell death did not hold: it appeared that such
cells could tolerate fragment loss to a greater degree than the
diploid line.
Since a large proportion of human tumour cells are aneup-
loid this complication could be a significant factor. In the
present study we have therefore studied four human tumour
cell lines of widely differing radiosensitivity in order to inves-
tigate the relationship between cell kill, as assessed by a
clonogenic assay, and micronucleus formation.
Materials and methods
Cell lines
Four human tumour cell lines were used: HX142 is a neurob-
lastoma cell line which was originally established from xenog-
rafted tumour tissue (Deacon et al., 1985); RT112 and
MGHU1 are both bladder carcinoma cell lines (Kato et al.,
1977; Masters et al., 1986); D283MED is a medulloblastoma
cell line (Friedman et al., 1985) and was kindly provided by
Dr D. Bigner. All cell lines were grown in monolayer in
Ham's F12 medium with 10% foetal bovine serum,
100 mgl-' streptomycin and 105 unitsl-' penicillin.
Table I shows the modal chromosome numbers and the
cell cycle distributions of the four cell lines. The former have
been taken from previous publications which include these
cell lines. The cell cycle distributions are mean values taken
from two or three experiments with each cell line. Despite
attempts to standardise the state of growth of the cells at the
time of analysis these results were rather variable. However,
there is a tendency for RT1 12 and MGH-U1 to have a lower
GI fraction and a higher S-phase fraction than the other two
cell lines. These cell cycle distributions were measured 24 h
after plating when cells were growing well. This is directly
comparable to the timing of irradiation of cultures for MN
experiments. These distributions are also likely to be accurate
for the survival experiments since these were prepared from
exponentially growing cultures.
Micronucleus test
Single-cell suspensions (0.4-1 x 104cells/plate) were plated
into 3.5 cm plastic Petri dishes containing a 15 mm plastic
coverslip (Thermanox). These were incubated at 370C in a
gassing incubator (3% 02, 5% CO2, 92% N2) for 24 h; (48 h,
for HX142) to allow the cells to establish a monolayer before
irradiation. The plating density was chosen to prevent
Table I
Modal
chromosome Cycle cell distributionb
Cell line numbera G S G2/M
HX142 46 71 (65-83) 18 (9-25) 11 (8-20)
D283MED 47 72 (69-74) 21 (17-25) 7 (6-9)
MGH-U1 47 45 (36-51) 45 (40-53) 10 (9- 11)
RTI12 46 41 (40-42) 45 (40-50) 14 (10-18)
aValue taken from previous publications (Bigneret al., 1988; McMil-
lanetal., 1990).bAnalysedbyflowcytometry. Valuesgivenaremeansof
a minimum oftwo independent measurements with the range ofvalues
given in parentheses. Cells were stained using propidium iodide and
analysed usinganOrthoCytofluoragraf50MasdescribedbyYangetal.
(1990).
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confluence being achieved during the course of the
experiments. Irradiations were carried out in a portable pers-
pex incubator at 37°C using a 1100 Ci (41 TBq) 'Co source.
Two hours after irradiation the cells were fed with fresh
medium containing 1 figml-' Cytochalasin-B (Sigma). After
incubating for 1-6 days in the presence of Cytochalasin-B,
the dishes were fixed with 70% ethanol and stained with 3%
Giemsa. The coverslips were then mounted on glass micro-
scope slides. A minimum of 100 BNC were scored per slide
using a Zeiss light microscope under oil (x 320). The number
of MN per BNC was recorded. A minimum of two (in some
cases six) independent experiments were performed for each
cell line in each stage of the characterisation and final
analysis of the MN test.
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Figure 1 Clonogenic cell survival curves for the four cell lines
(from McMillan et al., 1990, and Powell et al., 1992).
Preparation ofCytochalasin B
Cytochalasin-B was dissolved in dimenthylsulphoxide and
stored in aliquots at - 70°C at a concentration of 1 mgml 1.
Freshly thawed stock solution was diluted in Ham's F12
medium containing 10% foetal calf serum (Imperial Laboratories) to produce the required concentration.
Criteriafor identification ofmicronuclei
Only MN within binucleate cells were included and in addi-
tion they conformed to the following criteria: (1) they were
separate from the main nuclei; (2) they were no larger than
one-third the volume of the main nuclei; (3) their mor-
phology and staining properties were similar to those of the
main nuclear material.
Results
Clonogenic survival
The radiosensitivity of the four cell lines as measured by clonogenic assay have been published elsewhere (McMillan et
al., 1990; Holmes et al., 1990; Powell et al., 1992). For reference these survival curves are reproduced in Figure 1. The surviving fractions at 2 Gy (SF2) are 0.1 for HX142, 0.18 for D283MED, 0.53 for MGH-Ul and 0.62 for RTI12. This
range of sensitivities is representative of the spectrum of SF2 values seen in a larger number of human tumour cell lines (Steel et al., 1989).
Cytochalasin-B treatment
Cytochalasin-B is toxic at high doses. The growth of all four cell lines was affected to a similar degree by the presence of Cytochalasin-B and it was found that a 24 h treatment with Cytochalasin-B (1 tLgml-') reduced survival of RT112 and MGH-U1 to 70% and 40% respectively in a clonogenic
assay (data not shown). It was therefore important to find a dose which provided a satisfactory block in cytokinesis with-
out causing too much cell kill.
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Figure 2 Relationship of MN frequency to concentration of Cytochalasin-B. Cells were fixed 3 days after irradiation. Points are
means and standard errors.
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Figure 3 Effect of time after irradiation on MN frequency. Points are means and standard errors.
Figure 2 shows the effect of Cytochalasin-B on MN fre-
quency at 3 days. In the absence of Cytochalasin-B counts
were made in all cells rather than just BNC and in this
situation levels of MN per cell were extremely low in all
cases: 0.03 per cell for MGH-Ul, 0.02 for RT112, 0.003 for
D283MED and 0.02 for HX142. As expected, these levels
were generally lower than those obtained in the presence of
Cytochalasin-B due to the dilution effect of the separation of
daughter nuclei into separate cells. A plateau of MN fre-
quency is reached at 0.5fLgml'1 for MGH-U1, D283MED
and HX142, and at 1.0tLgml-' for RT112. We selected
1.Oigml-' Cytochalasin-B for all the cell lines, which led to
60-80% of cells being binucleate on day 3 for MGH-Ul,
HX142 and RT112 but a lower number of BNC (30%) for
D283MED.
Time ofMN expression
Sufficient time is needed after irradiation to allow cells to
progress through one nuclear division in order to display
MN formation. Figure 3 shows the expression of MN as a
function of time in the presence of 1 jAgml-' Cytochalasin-B.
For MGH-U1 and RT112 the MN values levelled out after 2
days. For D283MED, a plateau of MN frequency was
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Figure 4 Radiation dose-response curves for all four cell lines. Points are means and standard errors. Data were fitted using at
least squares linear regression analysis.
1Or
RT112
0.8F
0.6
0.41.
0.2
a.)
z
1or
0.8~
0.6 F
0.4[
0.2
0.0
6 7
a.) CU
a) 4C
a)
C
0._
z
e-
HX142
2.0
1.6
1.2
0.8
0.4
0.0 0 2 4 6 8
lnl-n,- - V.V
2
2.4rMN FORMATION IN HUMAN TUMOUR CELLS 105
:5
-
c5
0~ ~ ~
4 A- ,'
.c3~~~~~~~~~~~~~~~~J
(D
'2
CY _ <: 2
0.0 0.5 1.0 1.5 2.0 2.5
MN per binucleate cell
Figure 5 Relationship of lethal lesions (- ln(SF) read from
curves in Figure 1) to MN frequency (from data points in Figure
4). Data were fitted using linear regression analysis. 0= RT1 12,
* = MGH-Ul, * = HX142, 0 = D283MED.
reached by 3 days. For HX142 of MN seemed to continue
rising slightly up to day 5. By days 5 and 6 the number of
multinucleate cells increased markedly in all cell lines which
severely complicates analysis. It was therefore considered that
day 3 was a satisfactory time at which to measure the
expression of micronuclei.
Micronucleusformation
For each of the four cell lines the number of MN per BNC
increased with dose of ionising radiation (Figure 4). The
increase is approximately linear in each case, although for
RT1 12 there is a suggestion of an upward curvature. Assum-
ing linearity, the MN induction values were 0.10 per Gy for
HX142, 0.11 per Gy for D283MED, 0.23 per Gy for RT112
and 0.21 per Gy for MGH-Ul. Contrary to our expectation
the two most sensitive lines (HX142 and D283MED) had
fewer MN at any given dose than the two resistant lines. This
difference also exists when the proportion of cells with MN is
plotted against dose (not shown) rather than MN per
cell.
Relationship between cell kill and MNformation
Figure 5 shows the MN per BNC against the number of
lethal lesions for the range of doses used. For this the
number of lethal lesions was calculated as - ln (SF) from
the curves in Figure 1. The relationship is not the same for
all cell lines. For RT112 and MGH-Ul approximately 1 MN
corresponded to 1.4 lethal events. However, for HX142 and
D283MED the presence of one MN per BNC translated to
12.8 and 7.0 lethal lesions respectively, if the lines in Figure 5
were extrapolated.
Discussion
This study has examined the relationship between the
incidence of micronuclei in human tumour cells with
clonogenic cell survival in order to evaluate the possible use
of the MN test as a predictive test of tumour cell radiosen-
sitivity. Despite careful attention to the parameters of the
MN test, including cytochalasin dose and timing of analysis,
it was found that the MN test did not rank the cell lines in
the same order of sensitivity as was done with clonogenic cell
survival. Thus, a straightforward interpretation of these
results is that the MN test is not a useful predictive test.
Breakdown in a direct relationship between cell death and
MN formation has been detected previously in other contexts.
Chan (1990), for example, found the MN fre-
quency relationship
to be different for a given level of cell kill
cells were irradiated at high and low dose rates. Wandl
(1989) found a good linear relationship between sur-
and MN frequency in a series of human renal cell
carcinomas examined soon after removal from the patient,
but this relationship was not the same for each tumour. Also
van Beuningen et al. (1981) found that hyperthermia in-
creased MN formation without altering clonogenic cell sur-
vival.
As well as the implications for predictive testing the finding
of a lack of a simple relationship between MN frequency and
cell kill is of interest mechanistically. In their studies on
Syrian hamster cells, Revell (1983) found that any drift away
from a pure diploid cell line upset the relationship between
MN and inhibited growth, therefore it is perhaps not surpris-
ing that the exponentially growing human tumour cells do
not conform to a 1:1 relationship. The explanation for this
could be partly practical and partly biological.
One feature of the Revell studies was they were performed
on cells irradiated while synchronised in GI. This has the
value that any chromosome fragment formed will be reflected
in a genetic loss from both daughter cells at the first cell
division. When cells are irradiated post-S-phase, however, it
is chromatid fragments which are formed. Thus only one of
the daughter cells may be affected. A chromosome fragment
loss would therefore be reflected in a reduced colony forma-
tion whereas chromatid fragment loss would not decrease
colony number, it would merely make the colonies one
division behind the control colonies. It is not clear how
S-phase cells would behave in this regard, although
chromatid-type aberrations outnumber chromosome-type
aberrations in cells irradiated in S-phase. Due to the asyn-
chronous growth of the cell lines in the present study and the
apparent differences in the cell cycle distributions we must
consider what effect this would have on our results.
First of all the lack of synchronisation in all the cell lines
would lead to MN having a reduced effect on colony forma-
tion as the damaged G2/M cells (and perhaps at least some of
those in S-phase) would still form colonies if only one daugh-
ter cell was affected. This would lead to a MN:lethal lesion
ratio greater than 1. In each case here this ratio is less than 1.
The sensitive cell lines (HX142 and D283MED) do have
more cells in G1 for which each MN is more likely to contain
chromosomal fragments which would then reduce colony
formation. However, the scale of the differences in MN per
lethal lesion between the cell lines is unlikely to be fully
explained by these differences in cell cycle distribution.
The influence ofploidy should also be considered as Revell
(1983) found that cells with more chromosomes suffered
increased damage but they also exhibited greater tolerance of
that damage. The four cell lines in this study all have very
similar modal chromosome numbers, therefore ploidy would
seem to be unimportant. Nevertheless, the cell lines do not
have normal karyotypes, so that perhaps karyotypic ins-
tability or functional hemizygosity are influencing these
results.
The conclusion from the data with the sensitive lines is
that MN loss in the first division after irradiation is not a
large contributor to the death in these cells. At the extreme
this may suggest that they are dying from a non-mitotic
death. Apoptosis has recently been reported to be a cause of
death in gamma-irradiated cells (Stephens et al., 1991) but we
have found that although apoptosis can be detected in
D283MED this is not a significant effect in these cells (Ung
& McMillan, in preparation). Alternatively, these cell lines
may be inefficient at converting chromosome fragments into
MN or MN might only be expressed in later divisions after
irradiation, i.e. the fragment exclusion probability at the first
and subsequent divisions may differ between the cell lines. If
this factor did differ between our cell lines we would have
perhaps expected the distributions of MN per cell to differ
for a given average number of MN per cell. Our ability to
examine this is restricted due to the finding that the highest
MN frequency detected in HX142 and D283MED is low for
the dose range studied. However, in our analysis of the
distributions of the number of MN per cell (data not shown)
we have been unable to detect differences between the cell
lines. A detailed analaysis of the cytogenetic changes induced
by radiation in these cells is needed to investigate these106 C. BUSH & T.J. McMILLAN
possibilities.
Overall the data presented suggest that the MN test may
not be a satisfactory rapid test of the radiosensitivity of
human tumour cells, although it remains to be fully tested
within a single tumour type. However, it may provide useful
information regarding the way different cells handle
radiation-induced damage.
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